InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
6
Disclosed sells
0
T+90 hit rate
43%
T+90 mean return
-19.4%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Collins Cooper C.. Officer active across 1 company, notably TherapeuticsMD, Inc.. Cumulatively, 10 disclosures have been logged. Breakdown: 6 buys · 0 sell. Total volume traded: €1.2m. History available since 17 August 2021. The latest transaction was filed on 18 February 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
8,500 shares0Common StockSEC:0000905148-25-000740:0
4,094 shares@ US$1.7340.5% of flowCommon StockSEC:0000905148-24-002363:0
Ideal exit: 19 May 2025 (T+270)
1,200 shares@ US$1.69880.2% of flowCommon StockSEC:0000905148-24-002340:0
Ideal exit: 18 May 2025 (T+270)
1,984 sharesCommon StockSEC:0001209191-22-046969:0
1,000,000 shares@ US$0.578544.0% of flowCommon StockSEC:0001209191-21-066002
Ideal exit: 15 Aug 2022 (T+270)
1,000,000 shares@ US$0.57852.21% mcap44.3% of flowCommon StockSEC:0001209191-21-066002:0
Ideal exit: 15 Aug 2022 (T+270)
100,000 shares@ US$0.770.28% mcap5.7% of flowCommon StockSEC:0001387131-21-008733:0
Ideal exit: 14 May 2022 (T+270)
100,000 shares@ US$0.775.7% of flowCommon StockSEC:0001387131-21-008733
Ideal exit: 14 May 2022 (T+270)
96,864 sharesCommon StockSEC:0001387131-21-008436
96,864 sharesCommon StockSEC:0001387131-21-008436:0
10 of 10 declarations
About Collins Cooper C.
Collins Cooper C. is a director at TherapeuticsMD, Inc.
